(WASHINFRON, D.C.) – U.S. Senator Patty Murray (D-Wash.), a leading advocate for a strong, independent Food and Drug Administration, today released the following statement on the appointment of Dr. Kathleen Uhl, M.D. as the new Director of the FDA’s Office of Women’s Health.
“I have long supported making the FDA’s Office of Women’s Health a permanent fixture within the agency. American women deserve an advocate to head this office who will work to keep women’s health at the fore and who will ensure that science comes before gender bias and politics in everything from drug approval to clinical trials and research.
In August, the Office of Women’s Health lost one such strong voice – Dr. Susan Wood – who resigned in protest after science was clearly compromised in the application process of Plan B.
I hope that Dr. Uhl will serve as a strong voice for scientific integrity and take her role a scientific advocate for the health of American women seriously.
American women – along with all American consumers - must have faith that when they walk into their local pharmacy that the products they purchase are safe and effective and that their approval has been based on sound science.”